Abstract:Human respiratory syncytial virus (RSV) is an enveloped RNA virus and the leading viral agent responsible for severe pediatric respiratory infections worldwide. Identification of cellular factors able to restrict viral infection is one of the key strategies used to design new drugs against infection. Here, we report for the first time that the cellular protein BST2/Tetherin (a widely known host antiviral molecule) behaves as a restriction factor of RSV infection. We showed that BST2 silencing resulted in a significant rise in viral production during multi-cycle infection, suggesting an inhibitory role during the late steps of RSV's multiplication cycle. Conversely, BST2 overexpression resulted in diminution of the viral production. Furthermore, BST2 was found associated with envelope proteins and co-localized with viral filaments, suggesting that BST2 tethers RSV particles. Interestingly, RSV naturally downregulates cell surface and global BST2 expression, possibly through a mechanism dependent on ubiquitin. RSV's ability to enhance BST2 degradation was also validated in a model of differentiated cells infected by RSV. Additionally, we found that a virus deleted of NS1 is unable to downregulate BST2 and is significantly more susceptible to BST2 restriction compared to the wild type virus. Moreover, NS1 and BST2 interact in a co- immunoprecipitation experiment. Overall, our data support a model in which BST2 is a restriction factor against RSV infection and that the virus counteracts this effect by limiting the cellular factor's expression through a mechanism involving the viral protein NS1. Respiratory syncytial virus (RSV) is the main cause of severe lower respiratory tract infection in children with more than 30 million cases worldwide every year. The innate immune response is a major determinant of RSV disease severity and drives the adaptive immune response. BST2 is a key protein of the innate immune response, which restricts several enveloped viruses by tethering the viral particles at the plasma membrane preventing viral release. In the present study, we demonstrate for the first time that RSV multiplication is attenuated by BST2 expression. We reveal that BST2 co-distributes with RSV viral particles at the plasma membrane, leading us to propose that BST2 behaves as a restriction factor by tethering RSV particles at the surface of infected cells. Interestingly, we report that RSV is able to downregulate cell surface BST2 expression. Finally, we discovered that RSV NS1 protein interacts with BST2 and participates to the mechanism by which RSV downregulates BST2. Moreover, the demonstration of RSV's counteraction to BST2 restriction in cells close to its natural targets underlines the relevance of these data and paves the way for new strategies of infection control.

SARS-CoV-2 Mediated Inhibition Of Respiratory Syncytial Virus

Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses

Influenza A Virus Inhibits RSV Infection via a Two-Wave Expression of IFIT Proteins

A complex remodeling of cellular homeostasis distinguishes RSV/SARS-CoV-2 co-infected A549-hACE2 expressing cell lines

SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response

Human Respiratory Syncytial Virus Nonstructural Protein NS2 Antagonizes the Activation of Beta Interferon Transcription by Interacting with RIG-I

Multiple layers of innate immune response antagonism of SARS-CoV-2

MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein

SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response

SARS-CoV-2 protein NSP2 enhances microRNA-mediated translational repression

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling

Respiratory syncytial virus infection provides protection against severe acute respiratory syndrome coronavirus challenge

Respiratory syncytial virus NS1 inhibits anti-viral Interferon-α-induced JAK/STAT signaling, by limiting the nuclear translocation of STAT1

How RSV Proteins Join Forces to Overcome the Host Innate Immune Response

Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics

Exploring viral respiratory coinfections: Shedding light on pathogen interactions

Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells

SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3

Epidemiological Consequences of Viral Interference: A Mathematical Modeling Study of Two Interacting Viruses

Antagonism of BST2/Tetherin, a new restriction factor of respiratory syncytial virus, requires the viral NS1 protein

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response